Longitudinal monitor of Jun N-terminal kinase pathway associated phosphatase reflects clinical efficacy to triple conventional disease-modifying anti-rheumatic drugs treatment in rheumatoid arthritis patients

[1] Aletaha D(2018)Diagnosis and management of rheumatoid arthritis: a review JAMA 320 1360-1372

[2] Smolen JS(2010)2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative Arthritis Rheum 62 2569-2581

[3] Aletaha D(2018)Diagnosis and management of rheumatoid arthritis in adults: summary of updated NICE guidance BMJ 362 k3015-36601

[4] Neogi T(2002)The dual specificity JKAP specifically activates the c-Jun N-terminal kinase pathway J Biol Chem 277 36592-57605

[5] Silman AJ(2016)Downregulation of the phosphatase JKAP/DUSP22 in T cells as a potential new biomarker of systemic lupus erythematosus nephritis Oncotarget 7 57593-1580

[6] Funovits J(2018)Burden of rheumatoid arthritis from a societal perspective: A prevalence-based study on cost of this illness for patients in China Int J Rheum Dis 21 1572-54

[7] Felson DT(2014)The phosphatase JKAP/DUSP22 inhibits T-cell receptor signalling and autoimmunity by inactivating Lck Nat Commun 5 3618-2038

[8] Bingham CO(2019)Efficacy and safety of various anti-rheumatic treatments for patients with rheumatoid arthritis: a network meta-analysis Arch Med Sci 15 33-ITC16

[9] Birnbaum NS(2019)Circulating JNK pathway-associated phosphatase level correlates with decreased risk, activity, inflammation level and reduced clinical response to tumor necrosis factor-alpha inhibitor in Crohn disease patients Medicine (Baltimore) 98 e16622-undefined

[10] Burmester GR(2016)Rheumatoid arthritis Lancet 388 2023-undefined

[1] Aletaha D(2018)Diagnosis and management of rheumatoid arthritis: a review JAMA 320 1360-1372

[2] Smolen JS(2010)2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative Arthritis Rheum 62 2569-2581

[3] Aletaha D(2018)Diagnosis and management of rheumatoid arthritis in adults: summary of updated NICE guidance BMJ 362 k3015-36601

[4] Neogi T(2002)The dual specificity JKAP specifically activates the c-Jun N-terminal kinase pathway J Biol Chem 277 36592-57605

[5] Silman AJ(2016)Downregulation of the phosphatase JKAP/DUSP22 in T cells as a potential new biomarker of systemic lupus erythematosus nephritis Oncotarget 7 57593-1580

[6] Funovits J(2018)Burden of rheumatoid arthritis from a societal perspective: A prevalence-based study on cost of this illness for patients in China Int J Rheum Dis 21 1572-54

[7] Felson DT(2014)The phosphatase JKAP/DUSP22 inhibits T-cell receptor signalling and autoimmunity by inactivating Lck Nat Commun 5 3618-2038

[8] Bingham CO(2019)Efficacy and safety of various anti-rheumatic treatments for patients with rheumatoid arthritis: a network meta-analysis Arch Med Sci 15 33-ITC16

[9] Birnbaum NS(2019)Circulating JNK pathway-associated phosphatase level correlates with decreased risk, activity, inflammation level and reduced clinical response to tumor necrosis factor-alpha inhibitor in Crohn disease patients Medicine (Baltimore) 98 e16622-undefined

[10] Burmester GR(2016)Rheumatoid arthritis Lancet 388 2023-undefined